Ind Swift Laboratories Ltd vs Remedium Lifecare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Ind-Swift Laboratories Ltd is ₹ 144.45 as of 06 May 15:30 . The P/E Ratio of Ind-Swift Laboratories Ltd changed from 2.3 on March 2025 to 1.2 on March 2024 . This represents a CAGR of -12.20% over 5 yearsThe P/E Ratio of Remedium Lifecare Ltd changed from 36.4 on March 2025 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 years The Market Cap of Ind-Swift Laboratories Ltd changed from ₹ 509.08 crore on March 2025 to ₹ 580.82 crore on March 2024 . This represents a CAGR of 2.67% over 5 yearsThe Market Cap of Remedium Lifecare Ltd changed from ₹ 73.38 crore on March 2025 to ₹ 0 crore on March 2024 . This represents a CAGR of -100.00% over 5 years The revenue of Ind-Swift Laboratories Ltd for the Dec '25 is ₹ 178.43 crore as compare to the Sep '25 revenue of ₹ 170.5 crore. This represent the growth of 4.65% The revenue of Remedium Lifecare Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 114.31 crore. This represent the decline of -100% The ebitda of Ind-Swift Laboratories Ltd for the Dec '25 is ₹ 25.9 crore as compare to the Sep '25 ebitda of ₹ 19.34 crore. This represent the growth of 33.92% The ebitda of Remedium Lifecare Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 10.62 crore. This represent the decline of -100% The net profit of Ind-Swift Laboratories Ltd changed from ₹ 1.01 crore to ₹ 9.52 crore over 7 quarters. This represents a CAGR of 260.37% The net profit of Remedium Lifecare Ltd changed from ₹ -2.05 crore to ₹ 0 crore over 4 quarters. This represents a CAGR of -100.00% The Dividend Payout of Ind-Swift Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Remedium Lifecare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Ind-Swift Laboratories Ltd

Ind-Swift Laboratories Limited is a part of the Ind-Swift Group and is based at Chandigarh, Punjab, India.
The Company is one of the leading manufacturers of APIs catering to global and domestic formulators.
Based in Chandigarh, India, the Company operated two advanced manufacturing facilities in Derabassi and Jammu, adhering to international standards.
Ind-Swift Laboratories Ltd. is recognised globally as a leader in the Macrolide Antibiotic sector, and its products are well-regarded by major pharmaceutical formulators worldwide. Ind-Swift Laboratories Limited was incorporated on January 4, 1995 as a joint venture between Ind-Swift Ltd and Punjab State Industrial Development Corporation.
Later, Ind-Swift purchased Punjab State Industrial Development Corporation equity to emerge as a single largest shareholder in the company.

About Remedium Lifecare Ltd

Remedium Lifecare Limited (Formerly known as 'Roxy Exports Limited) was incorporated in February 19, 1988.
Consequent to change in the business activities and accordingly, in order to keep the name of the Company in consonance with the new business activities, the Company changed its name from 'Roxy Exports Limited' to 'Remedium Lifecare Limited' vide a fresh Certificate of Incorporation on November 6, 2020 issued by the Registrar of Companies. The Company being a pharmaceutical company is aligned across two business verticals viz. products and services.
Products business comprises trading and sale of APIs and Intermediates to innovator and generic pharmaceutical players in both domestic and international markets including the regulated markets. Apart from this, the Company is engaged in the business of trading in Advanced Pharmaceutical Intermediates, Active Pharmaceutical Ingredients (API's) and other pharma products used viz.

FAQs for the comparison of Ind-Swift Laboratories Ltd and Remedium Lifecare Ltd

Which company has a larger market capitalization, Ind-Swift Laboratories Ltd or Remedium Lifecare Ltd?

Market cap of Ind-Swift Laboratories Ltd is 1,254 Cr while Market cap of Remedium Lifecare Ltd is 38 Cr

What are the key factors driving the stock performance of Ind-Swift Laboratories Ltd and Remedium Lifecare Ltd?

The stock performance of Ind-Swift Laboratories Ltd and Remedium Lifecare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Ind-Swift Laboratories Ltd and Remedium Lifecare Ltd?

As of May 6, 2026, the Ind-Swift Laboratories Ltd stock price is INR ₹144.45. On the other hand, Remedium Lifecare Ltd stock price is INR ₹0.44.

How do dividend payouts of Ind-Swift Laboratories Ltd and Remedium Lifecare Ltd compare?

To compare the dividend payouts of Ind-Swift Laboratories Ltd and Remedium Lifecare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.